Abstract

Persistent symptoms after mild traumatic brain injury (mTBI) represent a major public health problem. To identify neuroanatomical substrates of mTBI and the optimal timing for magnetic resonance imaging (MRI). This prospective multicenter cohort study encompassed all eligible patients from the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study (December 19, 2014, to December 17, 2017) and a local cohort (November 20, 2012, to December 19, 2013). Patients presented to the hospital within 24 hours of an mTBI (Glasgow Coma Score, 13-15), satisfied local criteria for computed tomographic scanning, and underwent MRI scanning less than 72 hours (MR1) and 2 to 3 weeks (MR2) after injury. In addition, 104 control participants were enrolled across all sites. Data were analyzed from January 1, 2019, to December 31, 2020. Mild TBI. Volumes and diffusion parameters were extracted via automated bespoke pipelines. Symptoms were measured using the Rivermead Post Concussion Symptoms Questionnaire in the short term and the extended Glasgow Outcome Scale at 3 months. Among the 81 patients included in the analysis (73 CENTER-TBI and 8 local), the median age was 45 (interquartile range [IQR], 24-59; range, 14-85) years, and 57 (70.4%) were male. Structural sequences were available for all scans; diffusion data, for 73 MR1 and 79 MR2 scans. After adjustment for multiple comparisons between scans, visible lesions did not differ significantly, but cerebral white matter volume decreased (MR2:MR1 ratio, 0.98; 95% CI, 0.96-0.99) and ventricular volume increased (MR2:MR1 ratio, 1.06; 95% CI, 1.02-1.10). White matter volume was within reference limits on MR1 scans (patient to control ratio, 0.99; 95% CI, 0.97-1.01) and reduced on MR2 scans (patient to control ratio, 0.97; 95% CI, 0.95-0.99). Diffusion parameters changed significantly between scans in 13 tracts, following 1 of 3 trajectories. Symptoms measured by Rivermead Post Concussion Symptoms Questionnaire scores worsened in the progressive injury phenotype (median, +5.00; IQR, +2.00 to +5.00]), improved in the minimal change phenotype (median, -4.50; IQR, -9.25 to +1.75), and were variable in the pseudonormalization phenotype (median, 0.00; IQR, -6.25 to +9.00) (P = .02). Recovery was favorable for 33 of 65 patients (51%) and was more closely associated with MR1 than MR2 (area under the curve, 0.87 [95% CI, 0.78-0.96] vs 0.75 [95% CI, 0.62-0.87]; P = .009). These findings suggest that advanced MRI reveals potential neuroanatomical substrates of mTBI in white matter and is most strongly associated with odds of recovery if performed within 72 hours, although future validation is required.

Highlights

  • Estimated to affect half the world’s population during their lives, traumatic brain injury (TBI) is a major public health problem and a leading cause of disability.[1]

  • White matter volume was within reference limits on first magnetic resonance scan after injury (MR1) scans and reduced on second magnetic resonance scan after injury (MR2) scans

  • Neuroanatomical Substrates and Symptoms Associated With Magnetic resonance imaging (MRI) in Mild TBI. These findings suggest that advanced MRI reveals potential neuroanatomical substrates of mild traumatic brain injury (mTBI) in white matter and is most strongly associated with odds of recovery if performed within 72 hours, future validation is required

Read more

Summary

Introduction

Estimated to affect half the world’s population during their lives, traumatic brain injury (TBI) is a major public health problem and a leading cause of disability.[1] Based on the level of consciousness on presentation, 70% to 90% of TBI is classified as mild.[1] This term, is clearly a misnomer, because 30% to 50%2-5 of those patients experience symptoms that persist beyond 6 months and disrupt relationships and employment.[6] symptoms may be reduced by early intervention,[4,7] the large numbers of patients with mild TBI (mTBI) prohibit unselected follow-up without overburdening the system. Because many patients recover fully, trials of early interventions using unselected populations with mTBI are underpowered. We need ways to enrich populations for clinical follow-up and interventional trials. Magnetic resonance imaging (MRI) offers the potential to improve our understanding of the pathophysiology underpinning patient outcomes and to identify patients at risk of unfavorable recovery

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call